ShareValue scores for 0R6Y.LSE: Valuation 50, Quality 38, Growth 44, Health 48.
0R6Y.LSELSE
Nordic Nanovector ASA
£0.04
(+4.09%)
0R6Y.LSELSE
Nordic Nanovector ASA
£0.04(+4.09%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Weak
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
5% to 16%
Rating
Trap Risk
Return
5% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
38
Weak
Business Strength
Growth
44
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
68
Bullish
Price Trend
Company Details
About
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Sector
IndustryN/A
ExchangeLSE
Market Cap$2M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1744
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026